Lady Gaga and fiancé announce new biotech startup as FTC eyes Amgen patents and Moderna-Merck vaccine advances

Lady Gaga and her fiancé have announced the formation of a new biotech startup, marking a rare foray of a pop culture figure into the life‑science sector.

The Federal Trade Commission has begun a challenge to Amgen's patent strategy for its Enbrel drug, signaling heightened regulatory scrutiny of biologic patent practices.

Moderna and Merck reported progress on their collaborative cancer vaccine, a development that follows a lengthy and complex research pathway.

The FDA released draft guidance addressing the use of generative AI in medical devices, outlining expectations for developers in this emerging area.